ATMP world tour 2022 topic #8 ’CDMO roles in ATMP development’.
“We welcome Dave Smith from Akron Bio and Ola Tuvesson from NorthX Biologics to present and discuss the critical functions of CMOs and their role in managing the challenges of adapting from traditional biologics to ATMPs.” LinkedIn: https://www.linkedin.com/feed/update/urn:li:activity:6936961483540938752
NorthX Biologics appoints industry veterans to its board of directors
Sweden-based NorthX Biologics which focuses on process development and GMP manufacture of advanced biological drugs, has announced the appointments of Lotta Ljungqvist, Richard Bergström, Mathias Uhlén and Lars Backsell to its ...
Research project for more stable mRNA medicines
Currently, mRNA medicines, such as vaccines, require freezers that can maintain −80 °C for large-scale handling and distribution. A new project has now started, with an aim to develop production ...